Foghorn Therapeutics Inc. Annual Nonoperating Income (Expense) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Foghorn Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2019 to 2023.
  • Foghorn Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $3.65M, a 4.22% increase year-over-year.
  • Foghorn Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $13.6M, a 10.2% increase year-over-year.
  • Foghorn Therapeutics Inc. annual Nonoperating Income (Expense) for 2023 was $13.7M, a 66% increase from 2022.
  • Foghorn Therapeutics Inc. annual Nonoperating Income (Expense) for 2022 was $8.26M.
  • Foghorn Therapeutics Inc. annual Nonoperating Income (Expense) for 2021 was -$586K, a 118% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $13.7M +$5.45M +66% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $8.26M +$8.84M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 -$586K -$317K -118% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 -$269K -$225K -511% Jan 1, 2020 Dec 31, 2020 10-K/A 2022-08-09
2019 -$44K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.